TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - Community
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade TELO?
Rallies community data for TELO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.
TELO Analyst Consensus
TELO analyst coverage data. Average price target: $0.00.
Common questions about TELO
How does the Rallies community trade TELO?
Rallies community data for TELO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for TELO?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for TELO when enough community data is available.
Is TELO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.